Skip to content
Recall Observatory FDA recall evidence

Device product

Enzyme linked immunosorbent assay, for herpes simplex virus, hsv-2

Z-1274-2021

February 08, 2021

Class II

Product summary

Firm
Siemens Healthcare Diagnostics, Inc
Event
Event 87381
Status
Terminated
Classification
Class II
Quantity
390 kits total (Domestic 366 kits, Foreign 24 kits)
Official record key
device-enforcement:Z-1274-2021

Official wording

Reason: Potential false positive HSV results. Siemens Healthcare Diagnostics, Inc. initiated a correction for ADVIA Centaur4P Herpes-2 lgG (HSV2) Onboard Stability and Calibration Frequency (Interval) Failures on the ADVIA Centaur XP System and ADVIA Centaur XPT System.

Code information: ***Updated as of 3/25/2021*** Lot #: B33255, B33269, B33413. UDI #: (01)00630414016726(10)B33255(17)20210625, (01)00630414016726(10)B33269(17)20210629, (01)00630414016726(10)B33413(17)20210819. Updated as of 3/25/2021

Distribution pattern: Domestic: AL, CA, FL, IL, MD, NJ, NY, TN, TX. Foreign: Nepal, Chile, Georgia, Spain.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Potential false positive HSV results. Siemens Healthcare Diagnostics, Inc. initiated a correction for ADVIA Centaur4P Herpes-2 lgG (HSV2) Onboard Stability and Calibration Frequency (Interval) Failures on the ADVIA Centaur XP System and ADVIA Centaur XPT System.